Physician profile
Marsha Marecki
NPI 1801955745
$752.68
in general payments reported to CMS, 2019-2025
9 companies · $652 in 2025
The $652 reported for 2025 was more than what 91% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $100 · 2025: $652.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $575 · Education: $178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $574.69 |
| Education | $177.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $429.13 | 2025 | Veozah |
| Viiv Healthcare Company | $125.00 | 2025 | Apretude |
| Terumo Medical Corporation | $66.67 | 2024 | Azur Cx Detachable, Navicross, Glidesheath Slender |
| Abbvie INC. | $33.76 | 2024 | |
| Sumitomo Pharma America, INC. | $27.35 | 2025 | Gemtesa |
| Averitas Pharma INC. | $23.10 | 2025 | Qutenza |
| Ucb, INC. | $19.48 | 2025 | Bimzelx |
| Bayer Healthcare Pharmaceuticals INC. | $14.47 | 2025 | |
| Exact Sciences Corporation | $13.72 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marsha Marecki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.